Williams-Sonoma Inc. (0LXC)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 248.87 |
|---|---|
| 52-week range | 165.00 – 264.28 |
| Return, 1 month / 3 months | +7.5% / +7.5% |
| Return, 1 year / 3 years | +31.3% / +253.7% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 33.9% |
| Worst drawdown (1 year) | -23.7% |
| Average daily value traded | 0.06M USD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Williams-Sonoma Inc. is a home furnishings retailer based in San Francisco, California. Through its family of brands, including Williams Sonoma, Pottery Barn and West Elm, the company sells cookware, kitchen tools, tableware, furniture, bedding, lighting and decorative accessories. It serves household customers through its own stores, catalogues and online channels, and it also operates a business-to-business division supplying furnishings to the hospitality and contract trade.
On this site Williams-Sonoma Inc. appears as a stock on the London Stock Exchange (UK), code 0LXC, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Williams-Sonoma Inc. (0LXC) trades on the London Stock Exchange in UK. It last closed at USD 248.87 on 27 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,153 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.3% and over the last three months it rose 7.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.2% | ||
| From 52-week high | -3.1% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.5% | ||
| 6-month return | 31.6% | ||
| 12-month return, skipping the last month | 22.2% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.7% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | +7.5% |
| 3 months | +7.5% |
| 6 months | +31.6% |
| 1 year | +31.3% |
| 3 years | +253.7% |
| 5 years | +199.9% |
Signals
| 50-day / 200-day average | 235.31 / 212.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | USD 0.7600 |
| 16 Jul 2026 | USD 0.7600 |
| 16 Apr 2026 | USD 0.7600 |
| 15 Jan 2026 | USD 0.6600 |
| 16 Oct 2025 | USD 0.6600 |
| 18 Jul 2025 | USD 0.6600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.